InvestorsHub Logo
Followers 38
Posts 324
Boards Moderated 0
Alias Born 10/09/2013

Re: erg61 post# 23233

Friday, 04/06/2018 12:47:52 PM

Friday, April 06, 2018 12:47:52 PM

Post# of 34605
Believe what he meant was that Tapimmune would have much greater bargaining power, once we see the initial Phase 2 results...a good thing to wait.

If the Phase 2 are good/great, and I believe that they even did a mock scenario to that effect [521 day to recurrence] then they will have multiple BP's looking to partner/buyout or substantial cash infusion.

Hoang seems to really believe that _Phase 2's will mirror Phase 1, that is my take from previous 3 conference calls. And his wife I believe was a principle on the one approved drug, I am sure she has given him some input on the data to date.

We will know in max 18 months, and possibly by year end/1st quarter 2019.

If DoD is looking to give yet another grant, then they have seem preliminary data, and are still encouraged.

I believe that this is going to heat up greatly once a sniff of Phase 2's get out.

Dilution will come, lets hope it's existing holders of warrants, and remember, even if all warrants are exercised we should still be under 20 mill OS, and that is a small number, if they truly have the goods.

GLTA
BLU
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News